naloxone drug
Evidence from:
primary |
all sources
Related entities (18)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| Dopamine D2 receptor | interacts_with | naloxone | — | 1 |
| morphine | interacts_with | naloxone | — | 1 |
| naloxone | interacts_with | [3H]DAMGO | — | 1 |
| naloxone | regulates | ACTH | — | 1 |
| naloxone | interacts_with | alcohol dependence | — | 1 |
| naloxone | protective_against | alcoholism | — | 1 |
| naloxone | interacts_with | buprenorphine | — | 1 |
| naloxone | regulates | cortisol | — | 1 |
| naloxone | regulates | cortisol response | — | 1 |
| naloxone | interacts_with | morphine | — | 1 |
| naloxone | risk_factor_for | opioid withdrawal | — | 1 |
| naloxone | associated_with | opioid withdrawal | — | 1 |
| naloxone | interacts_with | OPRM1 | — | 2 |
| naloxone | targets | OPRM1 | — | 2 |
| naloxone | regulates | OXT | — | 1 |
| naloxone | associated_with | vital signs | — | 1 |
| ondansetron | interacts_with | naloxone | — | 1 |
| OPRM1 A118G | interacts_with | naloxone | — | 1 |
Mentioned in (17)
Papers in which this entity is mentioned.
- Physician Reluctance to Intervene in Addiction: A Systematic Review. (2024)
- Association Between Benzodiazepine or Z-Drug Prescriptions and Drug-Related Poisonings Among Patients Receiving Buprenorphine Maintenance: A Case-Crossover Analysis. (2021)
- Genetics of substance use disorders in the era of big data. (2021)
- The role of oxytocin in alcohol and drug abuse. (2020)
- Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity. (2017)
- The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction. (2014)
- Pharmacogenetics of OPRM1. (2014)
- Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. (2012)
- The genetics of the opioid system and specific drug addictions. (2012)
- A genetic determinant of the striatal dopamine response to alcohol in men. (2011)
- Haplotype block structure of the genomic region of the mu opioid receptor gene. (2011)
- Pharmacological treatment of cannabis dependence. (2011)
- Molecular assays for characterization of alternatively spliced isoforms of the u opioid receptor (MOR). (2010)
- From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics. (2009)
- Protein kinases and addiction. (2008)
- Temporally graded retrograde amnesia of contextual fear after hippocampal damage in rats: within-subjects examination. (1999)
- Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. (1998)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| naloxone | drug | 17 | 37 |
| 10 mg/70 kg naloxone | drug | — | — |
| hospira inc. naloxone | drug | — | — |
| naloxone reversal | drug | — | — |